Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0N5BC
|
|||
| Former ID |
DIB003726
|
|||
| Drug Name |
Autolymphocyte therapy
|
|||
| Synonyms |
Autologous lymphocyte therapy, Cytogen; Autolymphocyte therapy, Cytogen; ALT (RCC),CYTOGEN; ALT (RCC), Cellcor; Autolymphocyte therapy (RCC), CYTOGEN; Autolymphocyte therapy (RCC), Cellcor
Click to Show/Hide
|
|||
| Indication | Hepatitis B virus infection [ICD-11: 1E51.0; ICD-10: B18.1] | Discontinued in Phase 3 | [1] | |
| Company |
Cellcor Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008700) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.